S&P 500   5,090.66 (+0.07%)
DOW   39,195.28 (+0.32%)
QQQ   436.91 (-0.26%)
AAPL   182.95 (-0.77%)
MSFT   410.39 (-0.31%)
META   484.11 (-0.42%)
GOOGL   143.56 (-0.37%)
AMZN   174.02 (-0.32%)
TSLA   193.50 (-1.98%)
NVDA   780.82 (-0.58%)
NIO   5.39 (-7.86%)
AMD   175.05 (-3.74%)
BABA   75.97 (-0.20%)
T   16.79 (+1.21%)
F   12.20 (+0.66%)
MU   85.23 (-0.79%)
CGC   3.21 (-4.75%)
GE   152.95 (+0.84%)
DIS   106.07 (-1.46%)
AMC   4.33 (-2.04%)
PFE   27.94 (+1.42%)
PYPL   58.95 (+1.03%)
XOM   103.69 (-1.02%)
S&P 500   5,090.66 (+0.07%)
DOW   39,195.28 (+0.32%)
QQQ   436.91 (-0.26%)
AAPL   182.95 (-0.77%)
MSFT   410.39 (-0.31%)
META   484.11 (-0.42%)
GOOGL   143.56 (-0.37%)
AMZN   174.02 (-0.32%)
TSLA   193.50 (-1.98%)
NVDA   780.82 (-0.58%)
NIO   5.39 (-7.86%)
AMD   175.05 (-3.74%)
BABA   75.97 (-0.20%)
T   16.79 (+1.21%)
F   12.20 (+0.66%)
MU   85.23 (-0.79%)
CGC   3.21 (-4.75%)
GE   152.95 (+0.84%)
DIS   106.07 (-1.46%)
AMC   4.33 (-2.04%)
PFE   27.94 (+1.42%)
PYPL   58.95 (+1.03%)
XOM   103.69 (-1.02%)
S&P 500   5,090.66 (+0.07%)
DOW   39,195.28 (+0.32%)
QQQ   436.91 (-0.26%)
AAPL   182.95 (-0.77%)
MSFT   410.39 (-0.31%)
META   484.11 (-0.42%)
GOOGL   143.56 (-0.37%)
AMZN   174.02 (-0.32%)
TSLA   193.50 (-1.98%)
NVDA   780.82 (-0.58%)
NIO   5.39 (-7.86%)
AMD   175.05 (-3.74%)
BABA   75.97 (-0.20%)
T   16.79 (+1.21%)
F   12.20 (+0.66%)
MU   85.23 (-0.79%)
CGC   3.21 (-4.75%)
GE   152.95 (+0.84%)
DIS   106.07 (-1.46%)
AMC   4.33 (-2.04%)
PFE   27.94 (+1.42%)
PYPL   58.95 (+1.03%)
XOM   103.69 (-1.02%)
S&P 500   5,090.66 (+0.07%)
DOW   39,195.28 (+0.32%)
QQQ   436.91 (-0.26%)
AAPL   182.95 (-0.77%)
MSFT   410.39 (-0.31%)
META   484.11 (-0.42%)
GOOGL   143.56 (-0.37%)
AMZN   174.02 (-0.32%)
TSLA   193.50 (-1.98%)
NVDA   780.82 (-0.58%)
NIO   5.39 (-7.86%)
AMD   175.05 (-3.74%)
BABA   75.97 (-0.20%)
T   16.79 (+1.21%)
F   12.20 (+0.66%)
MU   85.23 (-0.79%)
CGC   3.21 (-4.75%)
GE   152.95 (+0.84%)
DIS   106.07 (-1.46%)
AMC   4.33 (-2.04%)
PFE   27.94 (+1.42%)
PYPL   58.95 (+1.03%)
XOM   103.69 (-1.02%)

Waters (WAT) Competitors

$332.27
+1.72 (+0.52%)
(As of 11:21 AM ET)

WAT vs. ILMN, BIO, AVTR, RVTY, BIO.B, TXG, GMAB, ALNY, PHG, and LH

Should you be buying Waters stock or one of its competitors? The main competitors of Waters include Illumina (ILMN), Bio-Rad Laboratories (BIO), Avantor (AVTR), Revvity (RVTY), Bio-Rad Laboratories (BIO.B), 10x Genomics (TXG), Genmab A/S (GMAB), Alnylam Pharmaceuticals (ALNY), Koninklijke Philips (PHG), and Laboratory Co. of America (LH). These companies are all part of the "medical" sector.

Waters vs.

Waters (NYSE:WAT) and Illumina (NASDAQ:ILMN) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership, community ranking and media sentiment.

Waters currently has a consensus price target of $293.50, indicating a potential downside of 11.21%. Illumina has a consensus price target of $166.95, indicating a potential upside of 23.16%. Given Illumina's stronger consensus rating and higher probable upside, analysts plainly believe Illumina is more favorable than Waters.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Waters
1 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.86
Illumina
2 Sell rating(s)
9 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.32

94.0% of Waters shares are held by institutional investors. Comparatively, 92.2% of Illumina shares are held by institutional investors. 1.0% of Waters shares are held by company insiders. Comparatively, 0.1% of Illumina shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Illumina received 645 more outperform votes than Waters when rated by MarketBeat users. Likewise, 65.77% of users gave Illumina an outperform vote while only 54.65% of users gave Waters an outperform vote.

CompanyUnderperformOutperform
WatersOutperform Votes
429
54.65%
Underperform Votes
356
45.35%
IlluminaOutperform Votes
1074
65.77%
Underperform Votes
559
34.23%

In the previous week, Waters had 42 more articles in the media than Illumina. MarketBeat recorded 53 mentions for Waters and 11 mentions for Illumina. Illumina's average media sentiment score of 0.86 beat Waters' score of 0.09 indicating that Illumina is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Waters
10 Very Positive mention(s)
8 Positive mention(s)
23 Neutral mention(s)
7 Negative mention(s)
5 Very Negative mention(s)
Neutral
Illumina
6 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Waters has a net margin of 21.72% compared to Illumina's net margin of -25.78%. Waters' return on equity of 81.30% beat Illumina's return on equity.

Company Net Margins Return on Equity Return on Assets
Waters21.72% 81.30% 16.41%
Illumina -25.78%2.20%1.25%

Waters has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500. Comparatively, Illumina has a beta of 1.22, meaning that its share price is 22% more volatile than the S&P 500.

Waters has higher earnings, but lower revenue than Illumina. Illumina is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Waters$2.96B6.61$642.23M$10.8530.47
Illumina$4.50B4.78-$1.16B-$7.34-18.47

Summary

Waters beats Illumina on 10 of the 18 factors compared between the two stocks.


Get Waters News Delivered to You Automatically

Sign up to receive the latest news and ratings for WAT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WAT vs. The Competition

MetricWatersAnalytical instruments IndustryMedical SectorNYSE Exchange
Market Cap$19.48B$5.86B$4.98B$17.30B
Dividend YieldN/A0.40%2.91%3.57%
P/E Ratio30.476.6983.4620.25
Price / Sales6.617.052,903.377.26
Price / Cash22.5980.0487.6217.97
Price / Book16.992.974.345.93
Net Income$642.23M-$8.68M$112.46M$870.05M
7 Day Performance1.64%-1.38%0.45%-0.59%
1 Month Performance4.46%1.40%6.43%1.86%
1 Year Performance2.32%-2.82%8.37%87.64%

Waters Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ILMN
Illumina
4.5248 of 5 stars
$140.05
-2.3%
$166.95
+19.2%
-32.8%$22.24B$4.50B-19.0810,260
BIO
Bio-Rad Laboratories
4.8423 of 5 stars
$344.95
+1.3%
$493.75
+43.1%
-28.9%$10.06B$2.67B-16.058,200Positive News
AVTR
Avantor
4.5458 of 5 stars
$24.07
+1.3%
$26.14
+8.6%
+1.8%$16.33B$6.97B50.1514,500
RVTY
Revvity
3.8332 of 5 stars
$101.98
-0.5%
$118.91
+16.6%
N/A$12.59B$2.75B18.5416,700Analyst Revision
BIO.B
Bio-Rad Laboratories
0 of 5 stars
$352.91
flat
N/A-12.8%$10.29B$2.67B-16.427,900
TXG
10x Genomics
4.6805 of 5 stars
$47.46
-2.0%
$62.44
+31.6%
-6.8%$5.61B$618.73M-21.871,243
GMAB
Genmab A/S
3.9269 of 5 stars
$28.95
+0.8%
$50.00
+72.7%
-23.4%$19.13B$2.39B30.161,660Analyst Report
Analyst Revision
News Coverage
ALNY
Alnylam Pharmaceuticals
4.782 of 5 stars
$149.69
+1.8%
$225.90
+50.9%
-19.0%$18.85B$1.83B-42.052,100Analyst Report
Analyst Revision
PHG
Koninklijke Philips
4.0738 of 5 stars
$20.17
-0.7%
N/A+20.9%$18.73B$18.17B-35.3877,233
LH
Laboratory Co. of America
4.8866 of 5 stars
$215.65
-0.5%
$241.86
+12.2%
-10.2%$18.31B$12.16B46.1880,000Insider Selling

Related Companies and Tools

This page (NYSE:WAT) was last updated on 2/23/2024 by MarketBeat.com Staff